Blood glucose meters
In 2012 PHARMAC moved to sole supply of blood glucose meters and testing strips, which are mainly used by people with diabetes to test their blood sugar levels. The price reduction from changing to sole supply of the CareSens range of meters and strips meant savings of $10 million per year compared to previous spending, that can be used to fund other medicines.
Summary of responses to consultation
In March 2015 PHARMAC released a consultation document that looked at the future funding approach to blood glucose meters and test strips. The consultation provided information and asked questions to help inform PHARMAC’s approach for the funding of blood glucose meters and test strips.
PHARMAC received 313 individual responses to the consultation from consumers, consumer groups, health professionals and suppliers of blood glucose meters and test strips. People provided us with lots of different feedback and opinions on the questions and proposed approach.
Expressions of interest
We've begun our procurement process by releasing a document seeking Expressions of Interest (EOI) from suppliers of meters and test strips. This EOI will enable suppliers to let PHARMAC know they are interested in having their products funded in the future.
When the EOI closes, laboratory testing and initial end-user testing will occur as part of our first stage evaluation of the diabetes management products.
Until any decisions are made, CareSens meters and test strips will continue to be funded.
Last updated: 1 February 2016